55
DAFTAR PUSTAKA
1. Kay AB. Mechanism and treatment of allergic rhinitis. In: Kerr AG, editor. ScottBrown’s Otolaryngology Rhinology. Fifth ed. London: Butterworth, 1987:93-8
2. Durham SR. Mechanisms and treatment of allergic rhinitis. In: Kerr AG, editor. Scott Brown's Otolaryngology Rhinology. Sixth ed. Oxford: Butterworth, 1997 : 461-3
3. Nathan RA, Mestzer EO, Selner JC, Stroms W. Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol 1997; 99 Suppl: 808-14
4. Ishizaka K and Ishizaka T. Alergy In: William E P. Fundamental Imunology. 2nd ed. Raven Press New York.: 867-88
5. Sumarman I.Strategi Pengobatan Rasional Rinitis Alergi Perenial: Ditinjau dari aspek biomolekuler reaksi inflamasi alergi. Konas Perhati. Semarang.1999:161-77
6. Sumarman I. Respon seluler dan humoral reaksi alergi dalam mukosa hidung. Dalam kursus penyegar penanggulangan penyakit alergi bidang THT, Pertemuan Ilmiah Tahunan Bukittinggi 1993; 14-18
7. Sheikh J.Rhinitis Allergic.[On line]: http:// www.emedicine.com/med/topic 104
8. Suprihati, Nina I, Madiapura T, Sumarman I. Penatalaksanaan rinitis alergi sesuai WHO-ARIA. BALI. Konggres Nasional XIII PERHATI-KL . 2003; 23: 68-75
9. Bousquet J. World Health Organisation initiative ARIA. A pocket guide for physicians and nurses;1-21
10.Van Cauwenberge P, Bachert C, Passalacqua G,Bousquet J. Consensus
statement on the treatment of allergic rhinitis. Allergy 2000;55:116-34
11.Creticos. The consideration of immunotherapy in the treatment of allergyc asthma. J Allergy Clin Immuno 2000;105:S 559-74
12.Bruce C, Gordon.Immunotherapy basics. Otolaryngol head and neck surg 1995;113:597-602
56
14.Akdis CA, Blaser K. Mechanisms of allergen specific immunotherapy. Allergy
2000;55:522-30
15.Haugaard L. Immunologic effect of immunotherapy. Allergy 1999;54:S58 56-58
16.Benjaponpitak S, Oro A, Maguire P, Marinkovich V, De kruyff R. The kinetics of change in cytokine production by CD4+T cells during convensional allergen immunotherapy. J Allergy Clin Immunol 1999;103:468-75
17.Lambrecht BN. Allergen uptake and presentation by dendritic cell. Current Opinion In Allergy and clinical immunology 2001;1:51-59
18.Von Bubnoff D. Geiger E, Bieber Thomas. Antigen presenting cells in allergy. J Allergy Cl in Immunol 2001;108 (3):329-39
19.Baraniuk JN. Pathogenesis of Allergic Rhinitis. J Allergy Clin Immunol 1997;99:S763-72
20.Abbas AK, Lichtman AH.B cell activation and antibody production. In: Celluler and moleculer immunology, Fifth edition. Philadelphia :WB Saunders Company.2003; 189-206
21.Abbas AK, Lichtman AH. Effector mechanism of immune responses. In : Celluler and moleculer immunology. Fifth edition. Philadelphia: WB Saunders Company 2003; 241-73
22.Constant SL, Kim B. Induction of Th-1 and Th-2 CD4+ T cell responses. Annu.Rev.Immunol.1997.15:297-322
23.Leonard WJ. Type I cytokines and interferons and their receptor. In : Paul WE, editor. Fundamental Imunology. Fifth edition. Philadelphia. Lippincott William & Wilkins; 2003.p.701-35
24.Ryan J. IL-4 and it's reseptor essensial mediator of the allergic response. J Allergy Clin Immunol.1997:99:1-5
25.Umetsu DT, De Kruyff RH. Th1 and Th2 CD4+ cells in human allergic diseases. J Allergy Clin Immunology 1997:100:1-5
26.Boehm U, Klamp T, Groot M, Howard J.C. Cellular responses to
interferon-Annu.Rev.Immunol.1997.15:749-95
57
28.Bousquet J, Lockey RF, Malling HJ. Allergen immunotherapy-therapeutic vaccines for allergic diseases. Annals of allergy, asthma and immunology 1998;81:401-5.
29.Moeliawan H. Imunoterapi praktis. Surabaya. Pertemuan Ilmiah Paru Milenium
2002. 2002;11-22
30.Brunet C, Bedard PM, Lavoie A, Jobin M, Hebert J. Allergic rhinitis to ragweed pollen. J Allergy Clin Immunol 1992;89:76-8
31.Peng Z, Naclerio R, Norman P, Adkinson F.Quantitive Ig E and IgG subclass responses during and after long term ragweed immunotherapy. J Allergy Clin Immunol 1992;89: 519-29
32.Till SJ, Francis JN, Aria KN, Durham SR. Mechanisms of immunotherapy. J Allergy Clin Immunol 2004;113:1025-34
33.Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR. Increases in
IL-12 messenger RNA cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Immunol 1997;99:254-60.
34.Klimek L, Dorman D, Jarman ER, Cromwell O, Riechelmann H, Reske-Kunz AB. Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokines levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis. Clin Exp Allergy 1999;29:1326-1335.
35Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH. Perkiraan besar sampel . Dalam : Sastroasmoro S, Ismael S, editor. Dasar-dasar metodologi penelitian klinis. Edisi ke 2. Jakarta. Sagung Seto:2002.p.259-86
36Choi SI, koh YI. Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized controlled trial. Ann Allergy Asthma Immunol 2002; 88:584-91.
37.Bertrand B, Jamart J, Marchal JL, Arendt C. Cetirizine and pseudoephedrine retard alone and in combination in the treatment of perennial allergic rhinitis; A double blind multicentre study. Rhinology 1996; 34:91-6
38.Larche M, Robinson DS, Kay B. The role of T lymphocytes in the patogenesis of asthma. J Allergy Clin Immunol 2003;111:450-63
39.Shi HZ, Qin XJ. CD4+CD25+ regulatory T lymphpcytes in allergy and asthma. Allergy 2005;60(8):986-95
